IndraLab

Statements


KCNA3 inhibits activation. 1 / 1
| 1

sparser
"Blocking Kv1.3 inhibits T EM cell activation and attenuates inflammation in autoimmunity, and as such, Kv1.3 has emerged as a promising target for the treatment of T EM cell-mediated autoimmune diseases."